Delivery Order SPE2DB22D2006-SPE2DB25FW1VG

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $1,888.25 and a completion date of April 4, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication, and has a firm fixed price ceiling value of $9,063.60. The contract has an ultimate completion date of January 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription medication, with a ceiling value of $2,265.90 and a completion date of May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,118.44, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription medication. The contract is a firm fixed price, non-set-aside agreement with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medication, with a ceiling value of $1,132.95 and a completion date of June 26, 2025. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $3,812.90 and a completion date of June 13, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $2,326.87 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. As a major vendor for the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has a ceiling value of $8,468.46 and a completion date of May 30, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA (CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has a ceiling value of $21,793.89 and a completion date of May 5, 2025. It is a firm fixed-price contract, which indicates a pre-determined price for the goods. This contract is not set aside for any specific business category. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,265.90 and a period of performance through April 17, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW1VG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription medication. The contract has a ceiling value of $1,324.17 and is a firm fixed price contract with a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00 and providing comprehensive global pharmaceutical support services to military healthcare programs through December 2026. The contract is not set aside for any specific business category.

Generated 9/16/25, 10:00 AM